Modified T Cells that Attack Leukemia Become First Gene Therapy Approved
Modified T Cells that Attack Leukemia Become First Gene Therapy Approved
Approval of Novartis cancer drug is “historic,” FDA says
Send us a link
In A 'Forgotten Experiment,' Biologists Almost Launched the Preprint Revolution
In A 'Forgotten Experiment,' Biologists Almost Launched the Preprint Revolution
A historian recounts the National Institutes of Health's 1960s pilot test of exchanging unreviewed manuscripts, and how publishers killed it.
China’s Embrace of Embryo Selection Raises Thorny Questions
Fertility centres are making a massive push to increase preimplantation genetic diagnosis in a bid to eradicate certain diseases.
Biohackers Encoded Malware in a Strand of DNA
Researchers planted a working hacker "exploit" in a physical strand of DNA.
Discredited Gene-Editing Researcher Vows to Clear His Name
A Chinese biologist whose team on Wednesday retracted a high-profile paper on a gene-editing technology has vowed to press ahead with experiments that he hopes will vindicate the potential rival to the CRISPR/Cas9 system.
CRISPR Patent Battle in Europe Takes a ‘Wild’ Twist
MilliporeSigma wins a key step in its claims to “knock-in” DNA with the powerful tool.
Biology's Roiling Debate Over Publishing Research Early
Posting scientific papers online, free to the public, seems like a great idea. But it's more complicated than it sounds.
Germans Provide Big Boost for Sequencing Often Ignored Organisms
Grant will help sequence thousands of plants, insects, and fungi
‘I Have to Be True To Who I Am as a Scientist’
Crispr inventor Jennifer Doudna talks about discovering the gene-editing tool, the split with her collaborator and the complex ethics of genetic manipulation.
Cancer Studies Pass Reproducibility Test
Project probing whether high-impact papers can be replicated releases latest results
Benefits that a Digital Healthcare System Could Bring Aren’t Out of Reach
There are many obstacles to bringing the power of 21st-century technology to the NHS. But that shouldn't stop us trying.
Facing Biomedical ‘Brain Drain’
Facing Biomedical ‘Brain Drain’
One in three scholars in field ‘deeply concerned’ about future research career prospects
The Remarkable Promise of Cell-Free Biology
New technologies could deliver the benefits of nature without the hassle of life
Should Biomedical Research Be Like Airbnb?
Consider biomedical preclinical and clinical research, in which the trusted service involves the exchange of papers, data, software, reagents, and so on.
Gene Editing Opens Doors to Seedless Fruit with No Need for Bees
Gene-edited seedless tomatoes don’t need pollinating to produce fruit – which could come in useful at a time when bees are on the decline
The Breakdown in Biomedical Research
Contaminated samples, faulty studies and inadequate training have created a crisis in laboratories and industry, slowing the quest for new treatments and cures.
Should You Be Able to Patent an Organism?
The synthetic biology community is divided.
Can “Digital Therapeutics” Be as Good as Drugs?
Entrepreneurs are betting on apps that improve—or just replace—prescription medication.
23andMe Given Green Light to Sell DNA Tests
US Food and Drug Administration says firm can provide consumers with information on genetic risks.
Mapping Digital Health Startups Across The Globe
While the US accounts for 75% of global digital health deal share, deal flow to international startups continues to climb.
As Blockbuster Drugs Fizzle, Biotech Looks Warily to the Next Big Thing
Several pricey drugs projected as best-sellers have flopped, unnerving the industry. Is the era of the biotech blockbuster over?
Measles Outbreak Across Europe
The World Health Organization says cases are climbing where immunisation coverage has dropped.
Europe Says University of California Deserves Broad Patent for CRISPR
Decision contrasts with U.S. ruling in long-standing battle over genome-editing tool
5 Biotech Products U.S. Regulators Aren’t Ready For
New techniques being used to produce our food or shape the environment raise regulatory questions.
HypDynamics
A data set interrogation tool in the field of cell and molecular biology.
Brain’s Reward System Earns Researchers €1 Million
Wolfram Schultz, Peter Dayan, and Ray Dolan have today been awarded the €1 million Brain Prize by Denmark’s Lundbeck Foundation.
WHO Publishes List of Bacteria for which New Antibiotics Are Urgently Needed
WHO Publishes List of Bacteria for which New Antibiotics Are Urgently Needed
WHO today published its first ever list of antibiotic-resistant "priority pathogens"—a catalogue of 12 families of bacteria that pose the greatest threat to human health.
AI Can Spot Skin Cancer as Well as a Trained Doctor
Researchers at Stanford University have created an AI algorithm that can identify skin cancer as well as a professional doctor.
Broad Institute Wins CRISPR Patent Battle
The dispute between researchers at UC Berkeley and the Broad Institute over the invention of the powerful gene-editing technique has been decided.
×